NetMeds acquires JustDoc for just under a million

NEW DELHI: Online pharmacy Net-Meds has acquired telemedicine portal JustDoc in a cash-and-stock deal, the second acquisition by the Chennai-based company, which had acquired hyperlocal drugs delivery startup Pluss last year.

NetMeds acquires JustDoc for just under a million While the terms of the transaction were not disclosed, Netmeds is believed to have paid a little under $1 million to acquire three-year-old JustDoc, which counts former Infosys senior executive TV Mohandas Pai, InMobi cofounder Mohit Saxena, TaxiForSure cofounder Raghunandan G as its angel investors and Singapore Angel Network and Tracxn Labs among its list of backers. All the investors of JustDoc, who had invested an undisclosed amount in the Bengaluru-based venture, are believed to be exiting the startup, post the closure of the deal.

“We were looking to add diagnostic services, given that our aim is to provide a more holistic health platform to our consumers, particularly those dealing with chronic health issues… Getting into diagnostics and telemedicine was a critical part,” Pradeep Dadha, chief executive of NetMeds, told ET.

This is the second acquisition by NetMeds, which competes with the likes of Sequoia Capital-backed 1mg. The latest buyout, according to Dadha, has been funded from the proceeds of the company’s last equity financing round, which was announced earlier this month.

NetMeds had raised $35 million in its Series-C round, which was led by Singapore-based Daun Penh Cambodia Group, and also saw participation from its existing set of investors, a list that includes Sistema Asia Fund, the venture capital arm of Russian conglomerate Sistema JSFC and Tanncam Investment, a Cambodian investment holding company, according to reports.

  • Related Posts

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy, the online medical platform emphasizes the importance of early prevention and regular health screenings to reduce the risk of diabetes. By encouraging individuals to undergo timely blood sugar tests,…

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    India’s pharmaceutical exporters have been offered a fresh business opportunity to expand their presence in Saudi Arabia, with Riyadh-based Al Hobail Medical Company seeking Indian manufacturing partners for the registration…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi